A device for home use that provides self-applied anodal transcranial direct current stimulation (A-tDCS) reduced fibromyalgia pain more than a sham treatment, according to a randomized clinical trial in Brazil involving 112 women. Exercise instructions and pain neuroscience education were included in the study. Those who used the A-tDCS device had a greater reduction in pain and less pain-related disability, according to the study. The trial found that A-tDCS, along with exercise and pain neuroscience education (PNE), improved disability due to pain.

Fibromyalgia affects 2.0% to 5.8% of the general population and is . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.